Plasma Caffeine Levels and Risk of Alzheimer’s Disease and Parkinson’s Disease: Mendelian Randomization Study

We leveraged genetic variants associated with caffeine metabolism in the two-sample Mendelian randomization framework to investigate the effect of plasma caffeine levels on the risk of Alzheimer’s disease and Parkinson’s disease. Genetic association estimates for the outcomes were obtained from the...

Descripción completa

Detalles Bibliográficos
Autores principales: Larsson, Susanna C., Woolf, Benjamin, Gill, Dipender
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102212/
https://www.ncbi.nlm.nih.gov/pubmed/35565667
http://dx.doi.org/10.3390/nu14091697

Ejemplares similares

Ejemplares similares